| DLS | DXIV | DLS / DXIV | |
| Gain YTD | 11.904 | 16.000 | 74% |
| Net Assets | 1.09B | 218M | 500% |
| Total Expense Ratio | 0.58 | 0.30 | 193% |
| Turnover | 45.00 | 8.00 | 563% |
| Yield | 3.50 | 2.36 | 148% |
| Fund Existence | 20 years | 2 years | - |
| DLS | DXIV | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 69% | 4 days ago 58% |
| Stochastic ODDS (%) | 4 days ago 75% | 4 days ago 62% |
| Momentum ODDS (%) | 4 days ago 77% | 4 days ago 88% |
| MACD ODDS (%) | N/A | 4 days ago 90% |
| TrendWeek ODDS (%) | 4 days ago 78% | 4 days ago 90% |
| TrendMonth ODDS (%) | 4 days ago 75% | 4 days ago 90% |
| Advances ODDS (%) | 4 days ago 81% | 6 days ago 90% |
| Declines ODDS (%) | 20 days ago 79% | 15 days ago 68% |
| BollingerBands ODDS (%) | 4 days ago 81% | 4 days ago 67% |
| Aroon ODDS (%) | N/A | 4 days ago 90% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TCMSX | 55.88 | N/A | N/A |
| Voya Small Cap Growth I | |||
| CDGRX | 13.31 | -0.01 | -0.08% |
| Copeland Dividend Growth Fund Class A | |||
| LGLAX | 58.77 | -0.10 | -0.17% |
| Lord Abbett Growth Leaders A | |||
| EIHSX | 14.05 | -0.06 | -0.43% |
| Eaton Vance Worldwide Health Sci I | |||
| STCAX | 19.15 | -0.12 | -0.62% |
| Virtus Silvant Large-Cap Growth Stk I | |||
A.I.dvisor indicates that over the last year, DLS has been closely correlated with ING. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if DLS jumps, then ING could also see price increases.